Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients

Dynamic Changes in Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 Levels During Wound Healing in Diabetic Rats

(2014) Chuan Yang et al.   JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION

Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment

(2010) Kinga Musiał et al.   CELL STRESS & CHAPERONES

Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease

(2010) Laura Mäkitalo et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment

(2009) Chrysanthos Symeonidis et al.   ACTA OPHTHALMOLOGICA

Subclinical keratoconus and inflammatory molecules from tears

(2009) I Lema et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Executive Summary: Standards of Medical Care in Diabetes--2009

(2009)   DIABETES CARE

High Matrix Metalloproteinase Production Correlates with Immune Activation and Leukocyte Migration in Leprosy Reactional Lesions

(2009) R. M. B. Teles et al.   INFECTION AND IMMUNITY

Inflammatory Markers in the Tears of Patients with Ocular Surface Disease

(2008) Arantxa Acera et al.   OPHTHALMIC RESEARCH

Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients

(2008) Masoud Reza Manaviat et al.   BMC Ophthalmology

The regulation of matrix metalloproteinases and their inhibitors

(2007) I CLARK et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY